Table 15.
Planned interim analysis grade ≥III AEs safety results [96].
Docetaxel (N = 44) | Docetaxel + ramucirumab (N = 46) | |
---|---|---|
Haematological toxicities | ||
Neutropenia | 36 | 28 |
Febrile neutropenia | 11 | 20 |
Anaemia | 5 | 9 |
Thrombocytopenia | 0 | 7 |
Non-haematological toxicities | ||
Fatigue | 11 | 33 |
Pneumonia | 9 | 13 |
Sepsis | 7 | 9 |
Stomatitis | 0 | 7 |
Diarrhoea | 2 | 7 |
AEs, adverse events.